SPOTLIGHT -
Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.
Late-Life Treatment-Resistant Depression
Blue Light Blockers: A Behavior Therapy for Mania
Tackling Treatment-Resistant Depression
Blue Light, Depression, and Bipolar Disorder
The First and Only 5HT1a Receptor Agonist for Major Depressive Disorder
Head-to-Head Comparison of Vortioxetine Versus Desvenalfaxine in Patients With Depression and Partial Response to SSRIs